OK
The Universal Selection Source:
Coatings Ingredients
Product News

BASF Unveils Kollicoat® Smartseal 30 D - Active Protection that Accelerates Aqueous Film Coating Operations

Published on 2011-08-01. Author : SpecialChem

FLORHAM PARK, NJ -- BASF will feature its broad range of pharmaceutical ingredients and the launch of Kollicoat® Smartseal 30 D at the Controlled Release Society (CRS) Annual Meeting and Exposition, July 30-Aug. 3. BASF will exhibit in booths 109 and 208 at the Gaylord National Hotel and Convention Center in National Harbor, Maryland. The CRS meeting and exposition hosts more than 1,600 attendees from the pharmaceutical industry with a focus on the science and business development of release technologies.

BASF will showcase its newest product, KollicoatSmartseal 30 D, the first water-based dispersion for taste masking and moisture barrier applications. It was developed to simplify and accelerate aqueous film coating operations, and enables formulators to effectively coat not only tablets, but also pellets and particles.

"Kollicoat Smartseal 30 D combines a strong protective effect with efficient processing," said Dr. Nigel Langley, Head of North America Technical Sales, Pharma Ingredients & Services at BASF. "We are convinced the new polymer will help customers to tackle challenges in formulating bitter or moisture-sensitive active ingredients."

Kollicoat Smartseal 30 D is highly impermeable to water vapor, helping preserve the potency of sensitive active ingredients. The polymer is stable in saliva and specifically soluble in gastric juice. This insures effective protection from unpleasant taste in the patient's mouth and rapid release and onset of active ingredient action in the stomach.

Broad portfolio of coating excipients

Kollicoat Smartseal 30 D complements BASF's existing tablet coatings portfolio. Under the Kollicoat brand, BASF markets a broad range of coating polymers and copolymers that are used to coat tablets, capsules and pellets, and to control the release of drugs from solid dosage forms. The Kollicoat family includes: Kollicoat IR and Kollicoat Protect instant release coatings, Kollicoat IR Color Coating Systems, Kollicoat MAE enteric coatings, Kollicoat SR 30 D sustained release coatings, and the new Kollicoat Smartseal 30 D protective coatings. These high quality products help customers streamline production processes, boost efficiency and reduce manufacturing costs.

With its polymer chemistry expertise and clear commitment to developing new pharmaceutical excipients, BASF creates solutions that contribute to its customers' success. The BASF global team strives to continuously develop and extend its portfolio of innovative excipients and active ingredients.

About BASF's Pharma Ingredients & Services

BASF produces and markets a broad range of active ingredients and excipients, as well as exclusive synthesis services for the pharmaceutical industry. These products are made using the latest technologies, to the highest quality standards and in compliance with cGMP guidelines.

About BASF Corporation

BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has approximately 16,400 employees in North America, and had sales of $17.7 billion in 2010.

BASF's portfolio ranges from chemicals, plastics, performance products, and agricultural products to oil and gas. As a reliable partner, BASF creates chemistry to help its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges, such as climate protection, energy efficiency, nutrition and mobility. BASF posted sales of more than €63.9 billion in 2010 and had approximately 109,000employees as of the end of the year.

Source: BASF


Halcyon Group 3rd R&D Innovation Summit
Back to Top